Assembly Biosciences (ASMB) Current Assets (2016 - 2025)
Historic Current Assets for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $236.8 million.
- Assembly Biosciences' Current Assets rose 14112.08% to $236.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $236.8 million, marking a year-over-year increase of 14112.08%. This contributed to the annual value of $115.5 million for FY2024, which is 1366.65% down from last year.
- Latest data reveals that Assembly Biosciences reported Current Assets of $236.8 million as of Q3 2025, which was up 14112.08% from $77.5 million recorded in Q2 2025.
- Assembly Biosciences' Current Assets' 5-year high stood at $236.8 million during Q3 2025, with a 5-year trough of $49.7 million in Q3 2023.
- In the last 5 years, Assembly Biosciences' Current Assets had a median value of $115.5 million in 2024 and averaged $127.2 million.
- As far as peak fluctuations go, Assembly Biosciences' Current Assets crashed by 5683.62% in 2023, and later soared by 14112.08% in 2025.
- Over the past 5 years, Assembly Biosciences' Current Assets (Quarter) stood at $154.2 million in 2021, then tumbled by 37.12% to $97.0 million in 2022, then surged by 37.97% to $133.8 million in 2023, then dropped by 13.67% to $115.5 million in 2024, then skyrocketed by 105.03% to $236.8 million in 2025.
- Its Current Assets stands at $236.8 million for Q3 2025, versus $77.5 million for Q2 2025 and $95.5 million for Q1 2025.